American Pharmaceutical Partners Announces ANDA Approval for Haloperidol Injection, USP

Apr 03, 2001, 01:00 ET from American Pharmaceutical Partners, Inc.

    LOS ANGELES, April 3 /PRNewswire/ -- American Pharmaceutical Partners,
 Inc. (APP) announced today that the company has received approval of an
 Abbreviated New Drug Application (ANDA) from the Food and Drug Administration
 (FDA) for Haloperidol Lactate Injection, a drug used to manage psychotic
 disorders.
     According to IMS, a market research firm, U.S. sales of Haldol were
 approximately $19 million in 2000.  The branded product, Haldol(R) is marketed
 by Ortho-McNeil Pharmaceuticals.
     American Pharmaceutical Partners, Inc, is a privately held integrated
 pharmaceutical company with over 800 employees.  APP is one of the leading
 manufacturers and marketers of injectable pharmaceuticals in the United States
 with facilities in Los Angeles, California; Schaumburg, Illinois, Melrose
 Park, Illinois, Grand Island, New York and Toronto, Canada.  For more
 information on the Company, visit APP's web site at www.appdrugs.com .
 
 

SOURCE American Pharmaceutical Partners, Inc.
    LOS ANGELES, April 3 /PRNewswire/ -- American Pharmaceutical Partners,
 Inc. (APP) announced today that the company has received approval of an
 Abbreviated New Drug Application (ANDA) from the Food and Drug Administration
 (FDA) for Haloperidol Lactate Injection, a drug used to manage psychotic
 disorders.
     According to IMS, a market research firm, U.S. sales of Haldol were
 approximately $19 million in 2000.  The branded product, Haldol(R) is marketed
 by Ortho-McNeil Pharmaceuticals.
     American Pharmaceutical Partners, Inc, is a privately held integrated
 pharmaceutical company with over 800 employees.  APP is one of the leading
 manufacturers and marketers of injectable pharmaceuticals in the United States
 with facilities in Los Angeles, California; Schaumburg, Illinois, Melrose
 Park, Illinois, Grand Island, New York and Toronto, Canada.  For more
 information on the Company, visit APP's web site at www.appdrugs.com .
 
 SOURCE  American Pharmaceutical Partners, Inc.